Clinical Trial Update: Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy of telbivudine with or without add-on tenofovir compared with entecavir in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Telbivudine (telbivudine)

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN